Hanley Peter J, Davis Paul B
Neuromonics Pty Limited, Chatswood, New South Wales, Australia.
Trends Amplif. 2008 Sep;12(3):210-22. doi: 10.1177/1084713808319942. Epub 2008 Jul 9.
Tinnitus has been challenging to treat with consistently positive results. The Neuromonics Tinnitus Treatment is a newly available approach to the treatment of clinically significant, problematic tinnitus (and reduced sound tolerance) that was developed with the intention of simultaneously addressing the auditory, attentional, and emotional processes underlying the condition. It uses a prescribed acoustic stimulus, customized for each patient's individual audiometric profile, which provides a broad frequency stimulus to address the effects of auditory deprivation, promotes relief and relaxation with the intention of reducing engagement of the limbic system/amygdala and autonomic nervous system, and applies the principles of systematic desensitization to address the attentional processes. This article describes the underlying principles behind this approach. It also summarizes evidence for clinical efficacy from controlled clinical studies and from a private practice clinical setting, where it has been shown to provide consistently positive outcomes for patients meeting suitability criteria.
耳鸣一直难以得到持续的积极治疗效果。Neuromonics耳鸣治疗法是一种新出现的治疗具有临床意义的、有问题的耳鸣（以及声音耐受性降低）的方法，其开发目的是同时解决该病症背后的听觉、注意力和情绪过程。它使用一种为每个患者的个体听力图定制的规定声学刺激，提供广泛的频率刺激以解决听觉剥夺的影响，旨在通过减少边缘系统/杏仁核和自主神经系统的参与来促进缓解和放松，并应用系统脱敏原理来解决注意力过程。本文描述了这种方法背后的基本原理。它还总结了来自对照临床研究和私人执业临床环境的临床疗效证据，在这些研究和环境中，已证明该方法能为符合适用性标准的患者持续带来积极结果。
